by Jordana Choucair | Feb 3, 2023 | Opioid/Substance Use Disorders
A bipartisan group of lawmakers urged President Biden to reinstate the Office of National Drug Control Policy’s director to a cabinet-level position to help improve the administration’s efforts addressing the overdose epidemic. The group commended Biden...
by Jordana Choucair | Jan 24, 2023 | Opioid/Substance Use Disorders
Premier Inc. released a three-part series examining the impact of Opioid Use Disorder (OUD) in the United States. The first blog found that treating OUD is costing hospitals more than $95 billion a year – just under 8 percent of all hospital expenditures. According to...
by Jordana Choucair | Jan 20, 2023 | Opioid/Substance Use Disorders
New data from the Centers for Disease Control and Prevention (CDC) found that doctors sent patients home with opioids after emergency department (ED) visits about 8 percent of the time in 2019–2020. The latest figures continue a downward trend from about 12 percent in...
by Jordana Choucair | Jan 19, 2023 | Opioid/Substance Use Disorders
West Virginia State Attorney General Patrick Morrisey announced the state has agreed to an $83 million settlement with Walgreens Boots Alliance Inc. to resolve a lawsuit alleging that the company’s failed control measures contributed to an oversupply of opioids...
by Jordana Choucair | Jan 12, 2023 | Opioid/Substance Use Disorders
New Jersey Attorney General Matthew Platkin announced the state will join a national settlement with several pharmacy chains and drug makers for their roles in the opioid epidemic. The state has signed five agreements with CVS, Walgreens, Walmart, Teva...
by Jordana Choucair | Jan 3, 2023 | Opioid/Substance Use Disorders
The Department of Justice (DOJ) filed a lawsuit against AmerisourceBergen, accusing the company of partially fueling the opioid crisis by failing to report hundreds of thousands of suspicious orders. The lawsuit asks for potentially billions of dollars in financial...
Recent Comments